Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.

Literature DB >> 4686177

BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.

Abstract

Pulmonary growths produced by intravenous injection of methycholanthrene-induced sarcoma cells were controlled or suppressed by specific immunostimulation with BCG-sarcoma cell inocula at subcutaneous sites or by intravenous treatment with BCG alone. The response was dependent upon the immunogenicity of the treated tumour so that in comparison, intravenous injection of BCG enhanced rather than suppressed pulmonary growths of transferred cells of several weakly immunogenic tumours including a spontaneously arising sarcoma and an epithelioma as well as a carcinogen-induced mammary carcinoma.

Entities: CellLine Chemical Disease Species

Mesh：

Substances：

Year: 1973 PMID： 4686177 PMCID： PMC2008826 DOI： 10.1038/bjc.1973.6

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

14 in total

1. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.

Authors: G L Bartlett; B Zbar; H J Rapp
Journal: J Natl Cancer Inst Date: 1972-01 Impact factor: 13.506

2. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.

Authors: A Rios; R L Simmons
Journal: Cancer Res Date: 1972-01 Impact factor: 12.701

3. Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors: R Evans; P Alexander
Journal: Nature Date: 1972-03-24 Impact factor: 49.962

4. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.

Authors: B Zbar; H J Rapp; E E Ribi
Journal: J Natl Cancer Inst Date: 1972-03 Impact factor: 13.506

5. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

Authors: B Zbar; I D Bernstein; H J Rapp
Journal: J Natl Cancer Inst Date: 1971-04 Impact factor: 13.506

6. Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats.

Authors: R Keller; V E Jones
Journal: Lancet Date: 1971-10-16 Impact factor: 79.321

7. Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma.

Authors: F R Eilber; E C Holmes; D L Morton
Journal: J Natl Cancer Inst Date: 1971-04 Impact factor: 13.506

8. The effect of inoculum size on the immune response to BCG infection in mice.

Authors: M J Lefford
Journal: Immunology Date: 1971-08 Impact factor: 7.397

9. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.

Authors: R W Baldwin; M V Pimm
Journal: Rev Eur Etud Clin Biol Date: 1971-11

10. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

Authors: I Parr
Journal: Br J Cancer Date: 1972-06 Impact factor: 7.640

25 in total

1. Editorial: BCG in cancer.

Authors:
Journal: Br Med J Date: 1976-06-19

2. Histopathology of BCG and thiotepa treated bladders.

Authors: P Guinan; M Shaw; V Ray
Journal: Urol Res Date: 1986

3. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors: M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal: World J Surg Date: 1977-09 Impact factor: 3.352

Review 4. The role of immunotherapy in the management of patients with malignant melanoma.

Authors: J E Goodnight; D L Morton
Journal: World J Surg Date: 1979-07-30 Impact factor: 3.352

5. Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.

Authors: A B Miller; H E Taylor; M A Baker; D J Dodds; R Falk; A Frappier; D P Hill; A Jindani; S Landi; A S Macdonald; J W Thomas; C Wall
Journal: Can Med Assoc J Date: 1979-07-07 Impact factor: 8.262

6. Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.

Authors: I T Magrath; J L Ziegler
Journal: Br Med J Date: 1976-03-13

7. Intratumoral BCG and Corynebacterium parvum therapy of canine mammary tumours before radical mastectomy.

Authors: A L Parodi; W Misdorp; J P Mialot; M Mialot; A A Hart; M Hurtrel; J C Salomon
Journal: Cancer Immunol Immunother Date: 1983 Impact factor: 6.968

8. The enhancement of tetrathyridial proliferation of Mesocestoides corti in mice by B.C.G.

Authors: R C Thompson; W J Penhale
Journal: Z Parasitenkd Date: 1978-07-04

9. A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy.

Authors: J R Scott; T L Feldbush; J M Covault
Journal: Clin Exp Immunol Date: 1977-12 Impact factor: 4.330

10. Experimental percutaneous renal embolization using BCG-saturated gelfoam.

Authors: K C Wright; C S Soo; S Wallace; M W McDonald; A Ayala
Journal: Cardiovasc Intervent Radiol Date: 1982 Impact factor: 2.740